The White House has announced plans for 55 million donated COVID-19 vaccination shots.

Spread the love

The Biden administration said on Monday that it will deliver 55 million of the promised 80 million doses of COVID-19 vaccine from the US stockpile to an international consortium that works with impoverished nations and targeted regional partners.

On June 3, the White House stated that the United States will ship at least 80 million COVID-19 vaccine doses to needy nations across the world by the end of the month. During that announcement, the first 19 million doses were designated to the COVAX project, with the remaining 6 million going to “regional priorities and partner recipients.”

In Monday’s announcement, the Biden administration said of the 55 million remaining doses, 41 million will go to COVAX and 14 million to Latin American and Caribbean countries in need.

Those countries include Brazil, Argentina, Colombia, Peru, Ecuador, Paraguay, Bolivia, Uruguay, Guatemala, El Salvador, Honduras, Haiti, Dominican Republic, Panama, and Costa Rica, along with member nations of the Caribbean Community, or CARICOM, organization.

READ ALSO:  McKinsey helps oversee recovery payouts to former clients

“For all of these doses, those most at risk, such as healthcare workers, should be prioritized, based on national vaccine plans,” the White House statement said. “In addition to sharing doses from our own vaccine supply, the Biden-Harris administration is also committed to working with our U.S. manufacturers to produce more vaccine to share with the world.”

Biden said before the G7 Summit the United States would purchase 500 million doses of the Pfizer/BioNTech vaccine and donate them to 92 low- and lower-middle-income countries, including African Union members.

“Sharing millions of U.S. vaccines with other countries signals a major commitment by the U.S. government,” the White House said. “Just like we have in our domestic response, we will move as expeditiously as possible, while abiding by U.S. and host country regulatory and legal requirements, to facilitate the safe and secure transport of vaccines across international borders.”

 428 

Leave a Reply